An analysis of the support and quality of live after the diagnosis and treatment of prostate cancer in the radiotherapy sector

• Autor(a) principal: FERREIRA, DICKSON C.
• Data de Publicação: 2020
• Outros Autores: DEL MASTRO, NELIDA L., INTERNATIONAL NUCLEAR ATLANTIC CONFERENCE
• Tipo de documento: Artigo de conferência
• Título da fonte: Repositório Institucional do IPEN
• Texto Completo: http://repositorio.ipen.br/handle/123456789/30583
• topic: data; diagnosis; information; medical records; neoplasms; patients; prostate; quality of life; radiotherapy; therapy; toxicity

Prostate cancer is the second most common cancer among men in most parts of the world. According to the National Cancer Institute (INCA), in Brazil there is an average of 61,000 new cases registered annually, while in the United States of America (USA) there was an average of 200,000 new cases. The advancement of technology and science has enabled a higher rate of cancer survival, especially when diagnosed early. Radiotherapy and radical prostatectomy have been shown to be effective in both controlling and curing prostate cancer; however, the patient??s satisfaction index, during the control period of the disease, in relation to the health team must be known. In the present work, patients being submitted to radiotherapy in a public hospital were ask to respond questions about the degree of satisfaction of support being receiving. Part of the research data obtained through questionnaire indicated that 65% of the patients ignore or know very little about the disease and 100% reported interest in having more information about prostate cancer. It was questioned whether during or after treatment there was need for support from health professionals, such as: physician, nursing, psychologist, social worker and physiotherapist, more than 60% reported having need of one or more specialist. The complete results of this survey will be used to elaborate guidance to radiotherapy units, through collecting data from the medical records and questionnaires relative to physical, social, psychological and emotional support, after the period of treatment with radiotherapy for prostate cancer.